As I recall there were discussions over a year ago on the Yahoo:SRDX message board raising concerns about Bovine endogenous retroviruses and the inherent problems with xeno-transplant approval.
Raising human islets seems to me the way to go. I just hope Novocell can pull it off. This would revolutionize diabetic treatment and make SRDX investors wealthy down the road, particularly if re-transplantation needs to occur every 3-5 years. Cha-ching!
Market Data 
Markets 
AI
